In Linköping, we have a quite rare scientific conference: a conference that has been arranged for over 20 years exclusively by undergraduate students! This conference is called KVIT, and it is arranged by the students in the cognitive sciences programme. The overall focus of the conference is the fascinating mix that is cognitive science: neurophysiology, psychology, IT, artificial intelligence, decision-support, user-interfaces, etc. The specific theme of this year was “Quality of life”, and at this conference we had been invited to give an oral presentation. This presentation was a bit unique because it for the first time outlined some less known long-term plans of our group: to merge and extend our research on a multi-level systems-level understanding of the brain based on mathematical modelling, with fundamental research on the relationship between quantum mechanics and possibilities for free will, and with research on different states of consciousness, such as sleep, narcolepsy, and different types of meditation.
Abstract is appended below, and the entire programme and more information of the conference can be found at the conference home page.
Abstract
One of the big promises of the Information Age is that of systems medicine: that our rapidly growing biomedical datasets will be possible to analyze using
advanced mathematical models, to produce things like automated
diagnoses, personalized treatments, and an improved drug and medical
device development. In this talk, I will go through some recent
developments in this field, to show that this promise is not a
far-fetched, science fiction utopia, but a rapidly approaching reality.
Focusing essentially on my own research, I will show how such
mathematical models now can be used to e.g. replace test animals when
developing new treatments for diabetes, and be used to better unravel
the complexity of the human brain. Using such tools, we can therefore
start to obtain a new type of holistic understanding of the human
organism, into which peces of knowledge both can be examined more
correctly, and subsequently be integrated into a useful picture of the
whole. I will therefore end by a comparison of this increasingly
holistic understanding with such found in e.g. yoga traditions for
thousands of years. What are the similarities and differences, and what
will it take to one day merge such understandings?
In the last week, we arranged a 2-day workshop on Biomedical engineering and decision-support. This workshop featured around 20 speakers and 30 attendees, from a wide variety of backgrounds. These backgrounds include all the steps involved in creation of decision-support systems (new biosensors, patient and personal health records, mathematical models, and the creation of usable interfaces), the testing and implementation of such systems (user-experience and user-groups, social scientists, health economy, implementation science, service design, and clinical end-users), and people from medical pedagogics, companies, and clinical decision-makers. This workshop was intended as a step towards further advancing the second-round of three already submitted VINNOVA applications (still pending), and – more generally – as a step towards the creation of a Linköping-based centre on Biomedical engineering and decision-support. This endeavor is open, so if you are interested in this process, send an email to either of the two arrangers: Elisabet or Gunnar Cedersund (elisabet.cedersund@liu.se and gunnar.cedersund@liu.se)
Some more information can be found at the workshop home page.
I’m Tim
Beishuizen, a Dutch student at Eindhoven, University of Technology. Currently I
am doing a dual master’s program Biomedical Engineering and Computer Science
and Engineering. At the ending of my Bachelor Biomedical Engineering I was
wondering what to do in my Master phase. My interests were broad and so I
finally chose to study three more years in a combination of two masters.
After searching
a good place to have an internship, I came in contact with Gunnar Cedersund and
the ISB group. Soon after we agreed on a project for my internship I came to
Linköping and started the project. The project is a continuation of the Markus
Karlsson’s Master’s Thesis. It is about creating simplified models of more
complex models to reduce complexity and computation time, also known as
metamodeling. I particularly focus on partial least squares regression in
combination with non-linear mixed effects to retrieve the best results.
Aside from
the project I am in Linköping to see something from Sweden as well. I haven’t
been in Sweden before and would like to experience what it has to offer. Taking
a break from life in The Netherlands, I can meet new people and find out the
Swedish living style.
2015 was the most expansive and important year so far, since we started, and there were many important things that happened.
The perhaps most important thing was that Gunnar Cedersund, the leader of the group, got a permanent position, a senior lecturer position (Swedish: Universitetslektor). This ensures that the group will live on for many years to come: Gunnar is bound to retire only in 2046, and the plan is to stay in Linköping and help lead this group at least until then! Apart from this, the new position also implied that Gunnar was elected into the board of our department. During 2015, we also recruited 3 new Ph.D. students: Markus Karlsson, Sebastian Sten, and Natasha Morales Drissi (see picture above). Markus will continue our work on MRI-based modelling of the liver, together with Peter Lundberg (who will act as main supervisor) and the other guys at CMIV. Sebastian and Natasha will focus on fMRI and how this can be combined with EEG data using mathematical modelling. Both of them will do both modelling and data collection, but Sebastian will focus mostly on modelling, and Natasha mostly on experiments. The main supervisor of both Sebastian and Natasha is Maria Engström.
In May of 2015, Elin Nyman was awarded a prize: “the best pre-clinical Ph.D. thesis published during 2014“. This prize is awarded by the Swedish association for diabetes research, and it is especially encouraging to notice that they think that our work om multi-level modelling of diabetes now is mature enough to really make a difference in the diabetes field.
Picture of Gunnar Cedersund giving a lecture at the award ceremony for Nytänkaren (photo by Anette Persson)
In December 2015, Gunnar Cedersund was awarded another prize: “Nytänkaren”. This prize is awarded by the “Swedish Fund for Research Without Animal Experiments“, who made a study visit in our group earlier in the year. During this visit, they became so enthusiastic over our results, and the general results of the field, that they decided to create a brand new award. Nytänkaren is a Swedish word, which means “The Innovator”, or “The Thinker of New Ideas”. This prize has also been reported in several news outlets, including the daily newspaper ETC, and Swedish television (see video below for English translation).
During the year, we also expanded and deepened our collaboration with AstraZeneca. This included the launching of several new projects, the publication of some first papers, and we also planned for the hiring of a new postdoc, to start in the Summer of 2016. Apart from this, Gunnar also gave a 3 day intensive course on systems biology.
In the summer of 2015, we had many internship students, and several of those have remained with us for the following year as well. A picture of our group during the summer is given below.
In the autumn of 2015, we spent 2 days in an internal workshop on the country side, to talk about joint decisions, ongoing work, and to create new visions for the coming years. Below you can see a few pictures from this event.
Finally, and perhaps most importantly, 2015 was also the year when we broke our own record in terms of number of publications: 4 published journal articles, 2 accepted journal articles, and 2 published book chapters. The full list is given below.
In summary, 2015 has been our most productive and expansive year: we have published the most number of publications, hired the most number of Ph.D. students, and received the most number of awards.
PUBLICATIONS (all were accepted during 2015):
Nyman E,
Lindgren I, Lövfors W, Lundengård K, Cervin I, Arbring Sjöström T, Altimiras J,
Cedersund G, Mathematical modeling
improves EC50 estimations from classical dose-response curves, FEBS J, 2015, 282(5):951-62.
Jullesson D, Johansson R, Rohini Rajan M,
Strålfors P, Cedersund G, Dominant
negative inhibition data should be analyzed using mathematical modeling:
re-interpreting data from insulin signaling, FEBS J, 2015, 282(4):788-802.
Karlsson M, Janzén DL, Durrieu L, Colman-Lerner
A, Kjellsson MC, Cedersund G, Nonlinear
mixed-effects modelling for single cell estimation: when, why, and how to use
it, BMC Syst Biol, 2015, 9:52.
Sips FL, Nyman E, Adiels M, Hilbers PA,
Strålfors P, van Riel NA, Cedersund G,
Model-Based Quantification of the Systemic Interplay between Glucose and Fatty
Acids in the Postprandial State, PLoS One, 2015,10(9):e0135665.
Schleicher J, Conrad T, Gustafsson M, Cedersund G, Guthke R, Linde J, Facing
the challenges of multiscale modelling of bacterial and fungal pathogen-host
interactions, Briefings in Functional Genomics 2016; doi: 10.1093/bfgp/elv064 (accepted during 2015)
Nyman
E, Rozendaal YJW, Helmlinger G, Hamrén B, Kjellsson MC, Strålfors P, van Riel
NAW, Gennemark P, Cedersund G, Requirements
for multi-level systems pharmacology models to reach end-usage: the case of
type 2 diabetes, J Royal Society Interface Focus, 2016, (accepted during 2015)
Cedersund G,
Prediction uncertainty: a comparison of recent method developments, in
Uncertainty in Biology, from Uncertainty in Biology, Edited by Gomez D and Tegnér
J, Springer-Verlag, 2016
Cedersund G, Samuelsson O, Ball G, Tegnér J, Gomez-Cabrero D, Optimization in
Biology: Parameter Estimation and the Associated Optimization Problem, from
Uncertainty in Biology, Edited by Gomez D and Tegnér J, Springer-Verlag, 2016
I already joined the
ISB group last summer, but left in late August to travel some of the countries in Southeast Asia. A couple of months have now passed and I have now returned to
the office for another 5 months.
I first got
into contact with the group during my Bachelor’s thesis last year, where I was
part of a two-man team of Engineering Biology students who did a project
regarding adiponectin release in fat cells. I then applied for an internship at
ISB-group, got accepted and started in June 2015.
Since then I have been working with the minimization of a previously created mathematical
model aimed at describing the desensitization of G protein-coupled β2 adrenergic
receptors which are crucial
for heart muscle contraction.
As I
already stated, I took a break from science and my studies for 4 months to travel
in Southeast Asia. There, my days were spent with things like hiking through
the rice fields in the mountain regions of northern Vietnam, joining a Muay-Thai
training camp in Thailand, scuba diving and of course relaxing by various
beaches throughout the region. Although last year was an amazing experience I
could not be more thrilled to be back at ISB group to continue with my project and
hopefully reach more satisfying results than I did last summer.
If you like
to know more about me, meet me, poke me, see me or speak with me about anything you want – then come
find me during working hours at Gunnar’s office at floor 13.
As a Medical Informatics student from the Netherlands, I will do an internship project for 4,5 month at ISB Group. I arrived just three weeks ago and I already feel at home both at ISB Group and Sweden in general (as you can see in the photo).
My background consists of three years of Medicine bachelor (in Rotterdam, NL) and three years of Medical Informatics bachelor (Amsterdam, NL). I switched from my first to my second bachelor, because I missed the technical challenge a lot. This internship will lead to a thesis that will conclude the last-mentioned bachelor.
The project I am doing at ISB Group consists of the making of an advanced model for the prediction of cardiovascular disease in diabetes patients. Hopefully this predictive model will become more accurate and adaptive to the individual patient than existing models. In order to achieve this, a Bayesian network will be used, instead of the more common regression analysis.
I’m really looking forward to the rest of the months here in Sweden! Luckily there are lots of activities for internationals in Linköping, which you can also visit if you’re not in an official exchange program like me.
On June 1, our annual project course – the Bachelor’s course for the ~30 students in Engineering Biology, TBMT33 – is having its final presentation day. This is a good chance to get a quick overview of existing projects within ISBgroup, and to see some of the different ways that mathematical modelling can be used as an integrated tool in experimental and clinical research. The schedule of the day is as follows.
All presentations in Linden, Campus US 8.15-9: Master Thesis presentation, “Quantitative translation of drugs’ effects on type 2 diabetes mellitus: from diabetic rodent models to patients”, Philip Blomström. Supervisors: Elin Nyman and Monika Sundqvist, Project done at AstraZeneca
9.15-9.45 “Intracellular insulin signalling and mechanisms of adiponectin release”. Supervisor: Rasmus Magnusson. Collaborating groups: Peter Strålfors (IKE), Cecilia Brännmark (Gothenburg Univ). 9.45-10.15 “Improvement of a Mathematical Liver Model for Diagnosis and Surgical Planning”, Supervisor: Markus Karlsson. Collaborating group: Peter Lundberg (IMH/CMIV)
10.15-10.30 Break
10.15-10.45 “Multi-level and multi-time scale modelling of glucose homeostasis disorders: monitoring in ICU and obesity drug simulations” Supervisor: Andrea Hjelm. Collaborating groups: Peter Strålfors (IKE), Peter Gennemark (AstraZeneca), Folke Sjöberg (IKE)
10.45-11.15 “Modelling the BOLD response in fMRI” Supervisor: Karin Lundengård. Collaborating group: Maria Engström (IMH/CMIV), Fredrik Elinder (IKE)
11.15-11.45 “Understanding desensitization – by examining cardiac myocytes and sensory neurons” Supervisors: William Lövfors and Rikard Johansson. Collaborating groups: Jordi Altimiras (IFM), Claudio Altafini (ISY)
12-13 Poster presentations of all projects outside of Berzelius.
Questions and more info: Gunnar Cedersund, gunnar.cedersund@liu.se
2013 continued on the new and higher level we had achieved in 2012, and continued to expand from there. We sent two people to Merrimack, we got a new Ph.D. student, we had even more people at ICSB, and we published our probably most important paper to date.
* In the spring of 2013, we did a new version of the annual course TSRT17: Systems biology modelling project. This involved around 35 students from the biomedical engineering programme (TB) and the industrial engineering biotechnology profile. As usual the projects dealt with real-life problems from different research groups, who gave the students real unanswered biological questions, which only can be answered via the usage of mathematical modelling. The students were divided into 6 projects, who worked with i) the understanding of heart desensitization, ii) insulin signalling and lipolysis in adipocytes, iii) facilitation in neurons, iv) myelin-measurements from MRI brain scans, v) estimation of liver fibrosis based on MRI time-series, vi) cell-to-cell differences in yeast cells. Group ii) did their work as a B.Sc. project. As previous years, we had a logotype-competition, and below you see a picture of the winners of their logotype.
* As usual, we recruited some of the most talented students from the course, to work in our group in various types of student projects, usually with associated scholarships. Some of these student include Philip Blomström, who worked with facilitation in neurons, and Mattias Köpsén, William Lövfors, and Fredrik Söderquist, who worked together with us, Mika Gustafsson and Mikael Benson to develop a method to estimate mechanistic ODE-models from omics data.
* We also had some older students around, and some of these were also on their way out towards their future careers. As illustrated in a previous blog entry, Linnea Bergenholm and David Janzén visited Merrimack Pharmaceuticals in Boston for a 6 month internship. This then led them to positions as Industrial Ph.D. students at AstraZeneca. This recruitment process illustrates the competitiveness of students who have been trained in our group: 2 of our students applied, both got the position. Apart from this, David Jullesson worked with the finishing of his paper, which then led him towards a Ph.D. position on Synthetic Biology with Jens Nielsen in Gothenburg. David also started up Linköping’s participation in iGEM, an international undergraduate synthetic biology competition. In this project modelling was used to some extent. Finally, Markus Karlsson worked during the entire spring semester with the application of the nonlinear mixed-effects modelling software Monolix to our liver model: this showed that our model-based approach outperforms all other image-analysis approaches, when it comes to generating biomarkers that can predict liver fibrosis.
* 2013 was also the year when a new Ph.D. student started: Mikael Forsgren (picture above). He had already been around for several years, working on modelling and experiments on the liver, and had just started a position at Wolfram MathCore, as a consultant in modelling. This Ph.D. position meant that we got him back as a 50% industrial Ph.D., and that we further strengthened our collaboration with MathCore.
* 2013 also saw the publication of our perhaps most important publication to date: our multi-level explanation to the origin of insulin resistance. In this paper, we had complemented our existing data for insulin signalling with new experiments, to get a first collection of systems-wide time-series and dose-responses for the main players in the insulin signalling network, both normally and in type 2 diabetes (examples in sub-figure A above). These unique data allowed us to, for the first time, test existing hypotheses regarding the origin of insulin resistance, i.e. the malfunction in the insulin signalling network seen in type 2 diabetes patients. We could then show that a specific feedback, from the protein mTORC1 to the protein IRS1, is a potential such explanation. If the network is perturbed in this feedback (red arrow, sub-figure B), the entire network switches from normal to diabetic signalling. This model has since its publication gained a lot of interest from pharmaceutical companies.
* Several of these showcases were presented at large international conferences, most notably the International Conference for Systems Biology (ICSB). ICSB was this year held in Copenhagen, and we went down with the largest group yet: around 15 people from at least 4 different research groups were present from Linköping. We were also well received, and Linköping had three oral presentations: Robert Palmér from the spin-off company MathCore presented our joint story on understanding the T2D drug Anakinra, Gunnar Cedersund and Markus Karlsson presented the above mentioned story on liver diagnosis, and Mikael Benson – not from our group, but also from Linköping – gave a keynote lecture on clinical end-usage of systems biology.
All in all, this year demonstrated that the previous successes of 2012 were not a one-time luck, but that we could sustain this level of activity and international visibility, and thereby bring high hopes for the coming year of 2014.
I’m Tim
Picture of Gunnar Cedersund giving a lecture at the award ceremony for Nytänkaren (photo by Anette Persson)
* 2013 also saw the publication of our perhaps most important 
